Month: <span>January 2022</span>

Home / 2022 / January
Understanding memory loss in Alzheimer’s disease
Post

Understanding memory loss in Alzheimer’s disease

by University of Seville Fig. 1. Generation of NrxnCTF transgenic mice. A) Schematic drawings showing the proteolytic processing of Nrxns by metalloproteases and PS (left) and the HA-tagged NrxnCTF transgene used in this study (right). The regions recognized by the HA and the cyto-Nrxn antibodies are indicated. LNS, Laminin/Neurexin/Sex hormone binding-globulin domain; TM, transmembrane region....

World’s fastest genome sequencer diagnoses genetic disease in hours
Post

World’s fastest genome sequencer diagnoses genetic disease in hours

By Michael Irving January 17, 2022 A new technique can sequence a person’s entire genome and diagnose genetic disease in just a few hours SSilver/Depositphotos Genome sequencing can be used to determine whether a patient’s illness is genetic, but it usually takes weeks to get results. A new ultra-rapid technique can sequence a person’s genome...

Post

Phages: Agents between good and evil

Viruses that infect bacteria could one day replace antibiotics because they precisely attack only specific pathogens. Researchers at ETH Zurich are now showing that this is not always the case. This new finding is important because bacterial viruses can transfer antibiotic resistance genes. Bacteriophages – phages for short – are viruses that infect only bacteria. To capture...

Protein Coating Protects Nanoparticles from Immune Attack
Post

Protein Coating Protects Nanoparticles from Immune Attack

JANUARY 17TH, 2022   CONN HASTINGS  MEDICINE, NANOMEDICINE Researchers at the University of Pennsylvania School of Medicine have created a new coating for nanoparticles that can help to protect them from attacks by the immune system. The approach, which uses naturally occurring proteins that can inhibit the complement system, can significantly reduce immune destruction of nanoparticles, meaning that more...

Post

Respiratory viruses that hijack immune mechanisms may have Achilles’ heel

WASHINGTON STATE UNIVERSITY One viral protein could provide information to deter pneumonia causing the body’s exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19. That viral protein is NS2 of Respiratory Syncytial Virus (RSV), and a study has found that if the virus lacks this protein, the human body’s immune response can...

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments
Post

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER IMAGE: “OUR GOAL IS TO BETTER PERSONALIZE THERAPY FOR PROSTATE CANCER PATIENTS, BY PROVIDING THE MOST PRECISE AND ACCURATE ESTIMATES OF THE BENEFIT OF HORMONE THERAPY.” ~ SENIOR AUTHOR, DANIEL E. SPRATT, MD. CREDIT: UNIVERSITY HOSPITALS CLEVELAND–Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is...

Additional antibodies may protect against COVID
Post

Additional antibodies may protect against COVID

JANUARY 17, 2022 by  Lund University Figure 1. Convalescent patient plasma reduces Spike-monocyte interaction. (A) Biotinylated Spike protein was conjugated to fluorescent (APC) streptavidin microspheres and was opsonized with three convalescent patient plasma concentrations (1%, 0.1%, and 0.01%). The beads were then mixed with THP-1 cells at a ratio of 2:1, and the association was measured using...

Israel study: 4th vaccine shows limited results with omicron
Post

Israel study: 4th vaccine shows limited results with omicron

JANUARY 17, 2022 by Josef Federman  Siblings wait to receive the COVID-19 vaccine at Clalit Health Services in Mevaseret Zion, Tuesday, Jan. 11, 2022. Credit: AP Photo/Maya Alleruzzo An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging...